Analytik Now Represent Microfluidics Corporation in the UK and Ireland
News Dec 16, 2014
Analytik has announced the representation of Microfluidics Corporation for the UK and Ireland market. Microfluidics, part of IDEX Corporation, is the manufacturer of unique high shear fluid processors, known as Microfluidizers, that can produce dispersions & emulsions of very tight particle size distributions, effectively de-agglomerate particles and disrupt cells in suspension.
Analytik has announced their partnership with Microfluidics Corporation (Westwood, MA, USA) for distribution and support of their Microfluidizer® fluid processors in the UK and Ireland. Microfluidics’ instruments are highly regarded in nano-enabled applications for uniform particle size reduction, cell disruption and bottom-up nanoparticle creation.
With scale-up guaranteed, it is not surprising that 17 of the top 20 global pharmaceutical companies have adopted Microfluidics’ technology for their processes among many companies in different industries.
Speaking about their new partnership, Analytik’s Product Specialist, James Anderson, provides background. “Microfluidics’ products complement our CPS Disc Centrifuge particle size analyzer that utilizes Differential Centrifugal Sedimentation (DCS). The CPS is one of the few instruments that can show the true results of any fluidic particle size reduction process. As such, it is ideal for proving Microfluidics’ performance advantages over the competition and allowing customers fine control over their particulate systems. This is particularly the case where solid particle dispersions are concerned.”
Continuing, James says “historically, Microfluidics is very strong in markets where scaling up from research and development to full-scale production is required; this transition is guaranteed by the operating principals of the instruments. The main markets are the pharma (emulsions, API suspensions), chemicals (pigments, nanoparticles), biotech (cell disruption) and food (emulsions) industries; and also academic/commercial research.”
From a product perspective looking at the benefits of the range, guaranteed scale-up is extremely important to users (the same interaction chambers are used from 1 ml to thousand litre batches).
Microfluidizers achieve the highest commercially available shear rate under a constant pressure profile. This results in the products having very consistent, repeatable and narrow particle size distributions.
Compared to other high shear technologies, less passes are required to achieve the same or better results, saving money through reduced energy consumption and faster processing.
Bioengineered Robotic Hand With Its Own Nervous System Will Sense TouchNews
A team of scientists from Florida Atlantic University are developing a first-of-its-kind bioengineered robotic hand that will grow and adapt to its environment.READ MORE
Rap Parody Wins the MicroTAS Video Competition 2017News
First prize awarded to two PhD candidates from Johns Hopkins University in Baltimore, Maryland.READ MORE
Joining Forces to Develop “Nephron-on-a-Chip" to Accelerate Drug Discovery in Kidney DiseaseNews
A new consortium to accelerate the discovery of novel drugs to treat kidney diseases was announced Monday 6 November. The NEPLEX (nephron on a chip with cellular and extracellular matrix complexity) consortium will combine key technologies to develop and build a novel drug discovery device ("Nephron-on-a-Chip").